| Date Filed | Type | Description |
| 09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Sold 8,164 shares
@ $1.1337, valued at
$9.3k
Sold 15 shares
@ $1.142, valued at
$17.1
Sold 3,445 shares
@ $1.1293, valued at
$3.9k
Sold 20 shares
@ $1.1114, valued at
$22.2 |
|
| 01/04/2023 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 200,000 shares
@ $0
Granted 900,000 options to buy
@ $1.13, valued at
$1M
|
|
| 01/12/2022 |
4
| TRABER PETER G (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 65,430 shares
@ $0 |
|
| 01/07/2022 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Sold 3,226 shares
@ $3.0859, valued at
$10k
|
|
| 01/05/2022 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 90,200 shares
@ $0
Granted 415,900 options to buy
@ $3.31, valued at
$1.4M
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2021 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Sold 3,636 shares
@ $4.39, valued at
$16k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| TRABER PETER G (Chief Medical Officer) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Bought 40,000 shares
@ $3.2356, valued at
$129.4k
|
|
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/14/2020 |
4
| TRABER PETER G (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 18,292 restricted stock units
@ $3.28, valued at
$60k
|
|
| 01/16/2019 |
4
| TRABER PETER G (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 12,121 restricted stock units
@ $4.95, valued at
$60k
|
|
| 01/10/2019 |
4
| TRABER PETER G (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 8,747 shares
@ $0 |
|
| 06/15/2018 |
4
| TRABER PETER G (President & CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Sold 100,000 shares
@ $7.51, valued at
$751k
Exercised 100,000 options to buy
@ $0.87, valued at
$87k
|
|
| 06/12/2018 |
4
| TRABER PETER G (President & CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Sold 70,000 shares
@ $5.8571, valued at
$410k
Exercised 70,000 options to buy
@ $0.87, valued at
$60.9k
|
|
| 05/24/2018 |
4
| TRABER PETER G (President & CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 125,000 options to buy
@ $4.16, valued at
$520k
|
|
| 01/17/2018 |
4
| TRABER PETER G (President & CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 125,000 options to buy
@ $5.87, valued at
$733.8k
|
|
| 01/10/2018 |
4
| TRABER PETER G (Director) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 8,747 restricted stock units
@ $0 |
|
| 01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2016 |
4
| TRABER PETER G (Director) has filed a Form 4 on Caladrius Biosciences, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $0.63, valued at
$9.5k
|
|
| 01/22/2016 |
4
| TRABER PETER G (President & CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 134,000 options to buy
@ $1.37, valued at
$183.6k
|
|
| 08/12/2015 |
4
| TRABER PETER G (President & CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Bought 2,000 shares
@ $2, valued at
$4k
|
|
| 06/04/2015 |
4
| TRABER PETER G (Director) has filed a Form 4 on NeoStem, Inc.|
Txns:
| Granted 10,000 shares
@ $0 |
|
|